Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ford

Showing results (441-450 of 568) with videos related to

Pageof 57
Sort By:
Journal of Medicinal Chemistry|March 31, 1995
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 2. 6-Halo and 6-alkoxy prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosineH Ford, M A Siddiqui, J S Driscoll, et al.
Journal of Patient-Reported Outcomes|April 4, 2023
Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraineJanet H Ford, Wenyu Ye, David W Ayer, et al.
Addiction Science & Clinical Practice|January 8, 2026
A mixed methods analysis of clinics' perspectives on community factors influencing access to medications for opioid use disorderSamuel Jaros, Maryam Abdel Magid, Hannah Cheng, et al.
BMC Health Services Research|October 26, 2019
Implementing integrated services in routine behavioral health care: primary outcomes from a cluster randomized controlled trialMehret T Assefa, James H Ford, Eric Osborne, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitroT Shirasaka, K Murakami, H Ford, et al.
Implementation Science : IS|October 17, 2025
A pragmatic approach to estimating the cost to deliver and participate in implementation strategiesHannah Cheng, Maryam Abdel Magid, Mark P McGovern, et al.
British Journal of Cancer|February 1, 1984
Carcinoembryonic antigen (CEA) expression and heterogeneity in primary and autologous metastatic gastric tumours demonstrated by a monoclonal antibodyM S Hockey, H J Stokes, H Thompson, et al.
Trials|January 26, 2010
The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later lifeAndrew H Ford, Leon Flicker, Kieran McCaul, et al.
Journal of Substance Abuse Treatment|May 15, 2007
Process improvement needs in substance abuse treatment: admissions walk-through resultsJames H Ford, Carla A Green, Kim A Hoffman, et al.
Implementation Science : IS|April 29, 2011
Disseminating quality improvement: study protocol for a large cluster-randomized trialAndrew R Quanbeck, David H Gustafson, James H Ford, et al.
Pageof 57

Showing results (441-450 of 568) with videos related to

Sort By:
Pageof 57
Journal of Medicinal Chemistry|March 31, 1995
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 2. 6-Halo and 6-alkoxy prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosineH Ford, M A Siddiqui, J S Driscoll, et al.
Journal of Patient-Reported Outcomes|April 4, 2023
Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraineJanet H Ford, Wenyu Ye, David W Ayer, et al.
Addiction Science & Clinical Practice|January 8, 2026
A mixed methods analysis of clinics' perspectives on community factors influencing access to medications for opioid use disorderSamuel Jaros, Maryam Abdel Magid, Hannah Cheng, et al.
BMC Health Services Research|October 26, 2019
Implementing integrated services in routine behavioral health care: primary outcomes from a cluster randomized controlled trialMehret T Assefa, James H Ford, Eric Osborne, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitroT Shirasaka, K Murakami, H Ford, et al.
Implementation Science : IS|October 17, 2025
A pragmatic approach to estimating the cost to deliver and participate in implementation strategiesHannah Cheng, Maryam Abdel Magid, Mark P McGovern, et al.
British Journal of Cancer|February 1, 1984
Carcinoembryonic antigen (CEA) expression and heterogeneity in primary and autologous metastatic gastric tumours demonstrated by a monoclonal antibodyM S Hockey, H J Stokes, H Thompson, et al.
Trials|January 26, 2010
The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later lifeAndrew H Ford, Leon Flicker, Kieran McCaul, et al.
Journal of Substance Abuse Treatment|May 15, 2007
Process improvement needs in substance abuse treatment: admissions walk-through resultsJames H Ford, Carla A Green, Kim A Hoffman, et al.
Implementation Science : IS|April 29, 2011
Disseminating quality improvement: study protocol for a large cluster-randomized trialAndrew R Quanbeck, David H Gustafson, James H Ford, et al.
Pageof 57